Member Info for RuckRover

C7, I said earlier you learn something new everyday but I didn’t expect revelations such as these. May God give you the strength to cope with whatever you have to face.

"cancer" cells

C7,
"I can only imagine Ruck it brought up many emotions in you, I did for me too"
Yes it did. As it happens, it is seven years today that my wife passed away so a painful anniversary.

I agree, it is a must watch. The animations were fantastic. I never realised that cancel cells could squeeze trough spaces that regular cells can't. You learn something new every day.

Deadly, thanks for the link, just watched it again.

C7, yes goose bumpy indeed - wow. What really impressed me was the way he presented it so factually and matter of fact when talking about something that would potentially kill him inside a year.

Sad that the lady with the stage 4 died. So sad and angry that the combo trial has been delayed. Boy, do we need them to get started. I’m with wild, I don’t care if I lose the lot (money) just get this thing nailed.

Just finished watching it. Absolutely fascinating!

C7, OK.

C7,
“Ruck, I get your point,”
Glad you do! What point was that?

Inan,

You just can’t help yourself having a dig regardless of what is being discussed can you lol. Unfortunately your tunnel vision doesn’t allow you to see alternative paths and so you see contradiction in what is in fact lateral thinking. Never mind.

Anyway, for the more open minded here......

I believe Moditope could be the more financially valuable long term. In the absence of sufficient funding, perhaps selling SCIB1 “lock stock and barrel” might be a way of providing such funds.

I believe that the QUICKEST commercialisation could come through “piggybacking” on Keytruda (albeit not as lucrative LONG term)

It is testament to Scancell’s rich estate of treatment options and IP that there are so many commercial options potentially available. I’m sure all us investors hope they ALL pay dividends eventually.

Ray,
Yes, plenty of options on the table.

Hopefully, we are now in a position to raise the necessary cash to pursue those options with Messers Diggle on board.

Crumbs,
Thanks. Personally I think piggybacking on Keytruda’s success will be Scancell’s quickest route to commercialisation. As Keytruda grows, so will Scancell. After that, who knows?

Crumbs,
What opportunities do you see for Scancell regarding this?

Improve response rates of CIs
Provide superior treatments stand alone
Treat the non-responders
All of the above?

knowlesi,

Having been invested for seven years and likely to wait another seven for a decent return, a few days isn't a big deal. Of course, the overreaction to another missed start may negatively affect the SP but this will soon recover once good news hits.

2cv,
Cliff Holloway Proactive interview 25/04/2019
" we expect dosing to commence before the end of this quarter" (ie end June)

Cliff Holloway Proactive interview 13/06/2019
" we expect the trial to commence in the coming weeks"

The second quote a little less specific. I'd be prepared for another slippage but hope it's not too long after the end of June.

C7, let's hope it is sooner lol.

My dad's actually starting to improve for the first time in over a year thanks for asking.

knowlesi,

assuming the trial DOES start on time it may be a good time to accumulate. If it Doesn't it may not as you quite rightly point out. BUT if this is really worth 17.2p TODAY, then even seeing your 7/8/9p pull back to 5/6p then it could be argued it is still a good time to accumulate. In fact, buying at any price under 17.2p may well turn out to have been a good time to accumulate.

Dragon,
You may well be right. Trinity Delta value us at 17.2p even taking into account the recent dilution. Don't forget, as they use NPV, that is a value TODAY not a some point in the distant future. With a bit of good news we could well be back up to 10p in the next few weeks. (IMO)

I lived in Evesham, Worcestershire.
I agree, there is much to be positive about. No need to be picky about everything. ATB

C7, early detection is crucial. Screening for colon cancer starts at 55 in some counties. Where I lived, it wasn’t until 60. This probably cost my wife her life.

This afternoon, I found out that my colleague who was diagnosed with breast cancer two years ago has found her husband has colon cancer. This was found through screening - where they live it starts at 55. Due to this, he has a good chance of making a complete recovery.

I’m sorry you feel I am goading Inan, but if you review the history you will find I made a genuine reply to a question and he went on the attack.

Get a good nights rest.

Crumbs,

The debate is whether there are in fact "hard to treat" cancers as I stated originally or whether they are all the same as Inanaco has tried to argue all afternoon.

Note the term "hard to treat" in the following: Perhaps someone could point out to Inanaco that the whole scientific community disagrees with him as do most of the more knowledgeable posters.

14th December 2017 CRUK Collaboration
“This collaboration will ensure that this innovative vaccine reaches patients sooner and could bring about urgently needed improvements for some cancers which can be hard to treat, including lung cancer – a disease where survival rates remain stubbornly low.”

31st January 2019 Interim Results

"Patents awarded with respect to the Moditope® platform and our on-going collaborations mean that we are now well positioned to develop Moditope® based therapeutics, such as vaccines and adoptive T-cell therapies, with the potential to address the unmet need across a broad range of hard to treat cancers."

"you can twist your posts to suit but you cannot change fact "

So says the master of post twisting!

For the record...

I think we all agree, cancers caught early are easier to treat, Late stage is harder to treat.

However, melanoma is more receptive to immunotheraphy than pancreatic cancer.

The word is immunogenic. hanks Bermuda on ADVFN for putting us all straight.